Clinical Investigation on the Use of Ophthalmic Solution Based on Sodium

Clinical Trial Description

Multicenter, prospective, observational, open-label, non- interventional clinical investigation evaluating the performance and safety of 4 daily instillations of the ophthalmic solution in the treatment of mild irritation of the ocular surface. ;

Study Design

Related Conditions & MeSH terms

Ocular Dryness

See also
	Status	Clinical Trial	Phase
	Completed	`NCT00803387` - Dry Eye and Irritation Comparison of Latanoprost With the Preservative Versus Travoprost Without Preservative	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT00803387 - Dry Eye and Irritation Comparison of Latanoprost With the Preservative Versus Travoprost Without Preservative

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05777798
Study type	Observational
Source	SIFI SpA
Contact
Status	Completed
Phase
Start date	March 14, 2023
Completion date	August 3, 2023

Clinical Investigation on the Use of Ophthalmic Solution Based on Sodium Hyaluronate in Treatment of Eye Discomfort

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms